The collagen meniscus implant market is estimated to be valued at US$ 470.7 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The collagen meniscus implant market involves products that are used in partial menisectomy procedures for treating damaged meniscus. Collagen meniscus implants are predominantly utilized in medial/lateral meniscus surgeries to replace functional units in damaged cartilage. These implants help reduce pain and facilitate a faster recovery compared to conventional therapies such as non-surgical and arthroscopic partial meniscectomy.

Market Dynamics:

The growth of the collagen meniscus implant market is primarily driven by the rising number of sports-related knee injuries and cases of osteoarthritis globally. According to data by the Nation Health Interview Survey in the U.S., over 250,000 people suffer from meniscus injuries each year. Additionally, factors such as the growing popularity of contact sports and adventure tourism activities have contributed to the increasing prevalence of meniscus tears, especially in the younger active population. The other key driver is the ability of these implants to shorten hospitalization periods and enable early return to daily activities and sports compared to traditional partial menisectomy procedures. This makes collagen meniscus implants a more cost-effective and preferable treatment option among both patients and healthcare payers.

SWOT Analysis

Strength: Collagen meniscus implant provides an alternative treatment option for meniscus injuries. It helps reduce pain and improve mobility in patients. The material is biocompatible and promotes natural tissue regeneration over time.

Weakness: The implant is not as durable as the natural meniscus tissue and requires a long recovery period. There are also concerns about degradation of the implant material over the years.

Opportunity: Rising sports injuries and road accidents are increasing the number of meniscal tears globally. The growing geriatric population is also prone to meniscal injuries. This expands the potential patient pool for collagen meniscus implants.

Threats: Strict regulatory approvals and reimbursement policies pose challenges for market players. Additionally, the availability of alternative treatment methods like meniscal scaffolds threaten the market demand.

Key Takeaways

The Global Collagen Meniscus Implant Market Size is expected to witness high growth, exhibiting CAGR of 4.4% over the forecast period, due to increasing prevalence of meniscal injuries among both young and elderly populations. Moreover, growing participation in sports and outdoor activities is leading to sports-related knee injuries.

Regional analysis:

North America dominates the global collagen meniscus implant market and is estimated to continue its dominance over the forecast period. This is attributed to growing obese population and increasing joint replacement surgeries in the region. The Asia Pacific region is expected to witness fastest growth owing to large patient pool, rising healthcare spending, and increasing medical tourism.

Key players operating in the Collagen Meniscus Implant market are Active Implants, Stryker, RTI Surgical, CONMED, Zimmer Biomet, Smith & Nephew, Arthrex, Biofixt, Ossur, MiMedx, and Bioventus. These players are focusing on new product launches and geographic expansion to garner higher market share.
For More Insights, Read- https://www.trendingwebwire.com/collagen-meniscus-implant-market-analysis-growth-forecast-outlook-2023-2030/